Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma

NCT05017610 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Per the PI-slow accrual

Conditions

Recurrent Glioblastoma
Recurrent Gliosarcoma

Interventions

DRUG: Liothyronine
DRUG: Lomustine
DRUG: Methimazole

Sponsor

Emory University

Collaborators

[object Object]